share_log
Breakings ·  May 30 19:05
Roivant Sciences Ltd - Consolidated Cash, Cash Equivalents and Restricted Cash of $6.6B at March 31, 2024, Supporting Cash Runway Into Profitability
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment